Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients.
Frontiers In Pharmacology
Matthaei, Johannes J; Brockmöller, Jürgen J; Steimer, Werner W; Pischa, Konstanze K; Leucht, Stefan S; Kullmann, Maria M; Jensen, Ole O; Ouethy, Typhaine T; Tzvetkov, Mladen Vassilev MV; Rafehi, Muhammad M
Publication Date: 2021
Variant appearance in text: SLC22A1: P117L; rs200684404
Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A.
Frontiers In Pharmacology
Rafehi, Muhammad M; Faltraco, Frank F; Matthaei, Johannes J; Prukop, Thomas T; Jensen, Ole O; Grytzmann, Aileen A; Blome, Felix G FG; Berger, Ralf Günter RG; Krings, Ulrich U; Vormfelde, Stefan V SV; Tzvetkov, Mladen V MV; Brockmöller, Jürgen J
Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review.
Medicine
Mofo Mato, Edith Pascale EP; Guewo-Fokeng, Magellan M; Essop, M Faadiel MF; Owira, Peter Mark Oroma PMO
Publication Date: 2018-07
Variant appearance in text: SLC22A1: Pro117Leu; rs200684404
Characterization of ADME gene variation in 21 populations by exome sequencing.
Pharmacogenetics And Genomics
Hovelson, Daniel H DH; Xue, Zhengyu Z; Zawistowski, Matthew M; Ehm, Margaret G MG; Harris, Elizabeth C EC; Stocker, Sophie L SL; Gross, Annette S AS; Jang, In-Jin IJ; Ieiri, Ichiro I; Lee, Jong-Eun JE; Cardon, Lon R LR; Chissoe, Stephanie L SL; Abecasis, Gonçalo G; Nelson, Matthew R MR